US Regulators Recommend "Pause" On J&J Vaccine Over Rare Blood Clots | Read
The United States has recommended "pausing" the use of Johnson&Johnson's vaccine against the coronavirus after the discovery of a "rare and severe type of blood clot" in six people. "Today FDA and @CDCgov issued a statement regarding the Johnson & Johnson #COVID19 vaccine. We are recommending a pause in the use of this vaccine out of an abundance of caution," US drug regulator Food and Drug Administration tweeted.
